Trial Profile
A Prospective Observational Study of Ertapenem in Outpatient Parenteral Antibiotic Therapy (OPAT) for Complicated Urinary Tract Infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary)
- Indications Bacterial infections; Urinary tract infections
- Focus Therapeutic Use
- 30 May 2016 Status changed from recruiting to completed.
- 30 May 2016 Results of ertapenem in outpatient parenteral antimicrobial therapy published in the Journal of Chemotherapy
- 13 Aug 2010 New trial record